Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance

被引:161
作者
Fine, RE
Boyd, BA
Whitworth, PW
Kim, JA
Harness, JK
Burak, WE
机构
[1] Breast Ctr, Marietta, GA 30060 USA
[2] Nashville Breast Ctr, Nashville, TN USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Univ Calif San Francisco, Oakland, CA USA
[5] Ohio State Univ, Columbus, OH 43210 USA
关键词
benign breast lesion; fibroadenoma; breast biopsy; mammotome;
D O I
10.1016/S0002-9610(02)00951-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: This study evaluates the safety, efficacy, and patient acceptance of a vacuum-assisted, hand-held biopsy device (Mammotome) in percutaneous removal of breast masses using ultrasound guidance. Methods: A multicenter, nonrandomized study evaluated 124 women with low-risk palpable lesions. Lesions less than or equal to1.5 cm and those >1.5 cm but less than or equal to3.0 cm were removed using I-gauge or 8-gauge probes, respectively. Follow-up evaluation was performed at 10 days postbiopsy. Results: The 8-guage probe was used to obtain biopsies from 75 patients, and the 11-gauge was used for 49 patients. Complete removal of the imaged lesion was similar between groups (99% 8-gauge versus 96% 11-gauge). Most complications were mild and anticipated. Most patients (97%) were satisfied with incision appearance, and 98% of patients would recommend the procedure to others. Conclusions: Percutaneous removal of palpable benign breast masses using the Mammotome system is feasible, safe, and yields high patient satisfaction. Long-term efficacy is being evaluated in the ongoing study. (C) 2002 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:332 / 336
页数:5
相关论文
共 15 条
[1]  
[Anonymous], BREAST IM REP DAT SY
[2]   Vacuum-assisted stereotactic breast biopsy - Histologic underestimation of malignant lesions [J].
Burak, WE ;
Owens, KE ;
Tighe, MB ;
Kemp, L ;
Dinges, SA ;
Hitchcock, CL ;
Olsen, J .
ARCHIVES OF SURGERY, 2000, 135 (06) :700-703
[3]  
DERSHAW DD, 1996, RADIOLOGY, V198, P3133
[4]   THE LIFETIME RISK OF DEVELOPING BREAST-CANCER [J].
FEUER, EJ ;
WUN, LM ;
BORING, CC ;
FLANDERS, WD ;
TIMMEL, MJ ;
TONG, T .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (11) :892-897
[5]   A prospective study of the removal rate of imaged breast lesions by an 11-gauge vacuum-assisted biopsy probe system [J].
Fine, RE ;
Israel, PZ ;
Walker, LC ;
Corgan, KR ;
Greenwald, LV ;
Berenson, JE ;
Boyd, BA ;
Oliver, MK ;
McClure, T ;
Elberfeld, J .
AMERICAN JOURNAL OF SURGERY, 2001, 182 (04) :335-340
[6]   Fibroadenoma of the breast [J].
Houssami, N ;
Cheung, MNK ;
Dixon, JM .
MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (04) :185-188
[7]   US-guided core breast biopsy: Use and cost-effectiveness [J].
Liberman, L ;
Feng, TL ;
Dershaw, DD ;
Morris, EA ;
Abramson, AF .
RADIOLOGY, 1998, 208 (03) :717-723
[8]   Analysis of cancers not diagnosed at stereotactic core breast biopsy [J].
Liberman, L ;
Dershaw, DD ;
Glassman, JR ;
Abramson, AF ;
Morris, EA ;
LaTrenta, LR ;
Rosen, PP .
RADIOLOGY, 1997, 203 (01) :151-157
[9]  
*NAT LIB MED, MEDL HLTH INF FIBR B
[10]   US-GUIDED AUTOMATED LARGE-CORE BREAST BIOPSY [J].
PARKER, SH ;
JOBE, WE ;
DENNIS, MA ;
STAVROS, AT ;
JOHNSON, KK ;
YAKES, WF ;
TRUELL, JE ;
PRICE, JG ;
KORTZ, AB ;
CLARK, DG .
RADIOLOGY, 1993, 187 (02) :507-511